Fernando Rodrigues files Form 144 to sell 25,086 shares

Fernando Madeira Rodrigues reported a proposed sale of 25,086 common shares tied to restricted stock vesting on 03/01/2026.

Rhea-AI Filing Summary

Fernando Madeira Rodrigues reported a proposed sale of 25,086 common shares tied to restricted stock vesting on 03/01/2026. The filing lists the shares as to be sold through Fidelity Brokerage Services LLC on the NYSE.

It also discloses prior sales in the past three months: 4,209 shares sold on 12/03/2025 for $31,483.32 and 16,314 shares sold on 03/02/2026 for $83,473.84.

Insights

Insider Transactions Analyst

Routine Form 144 notice of proposed sale tied to vesting; prior small dispositions reported.

The filing shows a proposed sale of 25,086 common shares arising from restricted stock vesting on 03/01/2026, with execution via Fidelity Brokerage Services LLC on the NYSE. This is presented as a standard affiliate sale notice.

Disclosures also record sales of 4,209 shares on 12/03/2025 for $31,483.32 and 16,314 shares on 03/02/2026 for $83,473.84. Timing and exact execution mechanics beyond the broker and date are not detailed in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for TDOC report?

The Form 144 reports a proposed sale of 25,086 common shares tied to restricted stock vesting on 03/01/2026. It names Fidelity Brokerage Services LLC and lists prior sales in the past three months.

Who is the reporting person on the TDOC Form 144?

The reporting person is Fernando Madeira Rodrigues, whose address is given as New York, NY. The filing attributes the proposed sale and prior dispositions to this reporting entity.

What prior insider sales are disclosed in the Form 144?

The filing shows sales of 4,209 shares on 12/03/2025 for $31,483.32 and 16,314 shares on 03/02/2026 for $83,473.84. These are reported as transactions during the past three months.

How will the shares be sold according to the filing?

The excerpt lists Fidelity Brokerage Services LLC as the broker and the market as the NYSE. Specific sale methods or price limits are not detailed in the provided content.

Are the shares being sold from compensation or direct holdings?

The proposed sale of 25,086 shares is described as resulting from Restricted Stock Vesting on 03/01/2026, indicating the shares stem from compensation arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 11:18 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037547
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Rodrigues Fernando M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	25086	124972.91	178396434	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Restricted Stock Vesting	Issuer			25086	03/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	12/03/2025	4209	31483.32
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	03/02/2026	16314	83473.84

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Fernando Madeira Rodrigues
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)